153 related articles for article (PubMed ID: 30105446)
1. Inhibition of glioma growth by a GOLPH3 siRNA-loaded cationic liposomes.
Yuan Z; Zhao L; Zhang Y; Li S; Pan B; Hua L; Wang Z; Ye C; Lu J; Yu R; Liu H
J Neurooncol; 2018 Nov; 140(2):249-260. PubMed ID: 30105446
[TBL] [Abstract][Full Text] [Related]
2. Co-delivery of GOLPH3 siRNA and gefitinib by cationic lipid-PLGA nanoparticles improves EGFR-targeted therapy for glioma.
Ye C; Pan B; Xu H; Zhao Z; Shen J; Lu J; Yu R; Liu H
J Mol Med (Berl); 2019 Nov; 97(11):1575-1588. PubMed ID: 31673738
[TBL] [Abstract][Full Text] [Related]
3. Dual-modified cationic liposomes loaded with paclitaxel and survivin siRNA for targeted imaging and therapy of cancer stem cells in brain glioma.
Sun X; Chen Y; Zhao H; Qiao G; Liu M; Zhang C; Cui D; Ma L
Drug Deliv; 2018 Nov; 25(1):1718-1727. PubMed ID: 30269613
[TBL] [Abstract][Full Text] [Related]
4. T7 peptide-functionalized nanoparticles utilizing RNA interference for glioma dual targeting.
Kuang Y; An S; Guo Y; Huang S; Shao K; Liu Y; Li J; Ma H; Jiang C
Int J Pharm; 2013 Sep; 454(1):11-20. PubMed ID: 23867728
[TBL] [Abstract][Full Text] [Related]
5. GOLPH3 promotes glioma progression via facilitating JAK2-STAT3 pathway activation.
Wu S; Fu J; Dong Y; Yi Q; Lu D; Wang W; Qi Y; Yu R; Zhou X
J Neurooncol; 2018 Sep; 139(2):269-279. PubMed ID: 29713848
[TBL] [Abstract][Full Text] [Related]
6. [Anti-glioma effect of combination of bFGF-siRNA and Vpr in nude mice].
Feng XQ; Wang JH; Xu XN; Zhang B; Wang SJ; Liu HS; Lin N
Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):725-8. PubMed ID: 21163059
[TBL] [Abstract][Full Text] [Related]
7. H
Zhou M; Jiang N; Fan J; Fu S; Luo H; Su P; Zhang M; Shi H; Zeng J; Huang Y; Li Y; Shen H; Zhang A; Li R
J Control Release; 2019 Sep; 310():24-35. PubMed ID: 31404556
[TBL] [Abstract][Full Text] [Related]
8. Golgi phosphoprotein 3 sensitizes the tumour suppression effect of gefitinib on gliomas.
Wang X; Wang Z; Zhang Y; Wang Y; Zhang H; Xie S; Xie P; Yu R; Zhou X
Cell Prolif; 2019 Jul; 52(4):e12636. PubMed ID: 31094020
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase D2 promotes the proliferation of glioma cells by regulating Golgi phosphoprotein 3.
Zhou X; Xue P; Yang M; Shi H; Lu D; Wang Z; Shi Q; Hu J; Xie S; Zhan W; Yu R
Cancer Lett; 2014 Dec; 355(1):121-9. PubMed ID: 25218347
[TBL] [Abstract][Full Text] [Related]
10. Multi-targeting NGR-modified liposomes recognizing glioma tumor cells and vasculogenic mimicry for improving anti-glioma therapy.
Huang D; Zhang S; Zhong T; Ren W; Yao X; Guo Y; Duan XC; Yin YF; Zhang SS; Zhang X
Oncotarget; 2016 Jul; 7(28):43616-43628. PubMed ID: 27283987
[TBL] [Abstract][Full Text] [Related]
11. Dual receptor-specific peptides modified liposomes as VEGF siRNA vector for tumor-targeting therapy.
Yang Z; Xiang B; Dong D; Wang Z; Li J; Qi X
Curr Gene Ther; 2014; 14(4):289-99. PubMed ID: 25039617
[TBL] [Abstract][Full Text] [Related]
12. Targeted shRNA-loaded liposome complex combined with focused ultrasound for blood brain barrier disruption and suppressing glioma growth.
Zhao G; Huang Q; Wang F; Zhang X; Hu J; Tan Y; Huang N; Wang Z; Wang Z; Cheng Y
Cancer Lett; 2018 Apr; 418():147-158. PubMed ID: 29339208
[TBL] [Abstract][Full Text] [Related]
13. Golgi phosphoprotein 3 promotes glioma progression via inhibiting Rab5-mediated endocytosis and degradation of epidermal growth factor receptor.
Zhou X; Xie S; Wu S; Qi Y; Wang Z; Zhang H; Lu D; Wang X; Dong Y; Liu G; Yang D; Shi Q; Bian W; Yu R
Neuro Oncol; 2017 Nov; 19(12):1628-1639. PubMed ID: 28575494
[TBL] [Abstract][Full Text] [Related]
14. GOLPH3 regulates the migration and invasion of glioma cells though RhoA.
Zhou X; Zhan W; Bian W; Hua L; Shi Q; Xie S; Yang D; Li Y; Zhang X; Liu G; Yu R
Biochem Biophys Res Commun; 2013 Apr; 433(3):338-44. PubMed ID: 23500462
[TBL] [Abstract][Full Text] [Related]
15. Homing of ICG-loaded liposome inlaid with tumor cellular membrane to the homologous xenografts glioma eradicates the primary focus and prevents lung metastases through phototherapy.
Xu HL; Shen BX; Lin MT; Tong MQ; Zheng YW; Jiang X; Yang WG; Yuan JD; Yao Q; Zhao YZ
Biomater Sci; 2018 Aug; 6(9):2410-2425. PubMed ID: 30039133
[TBL] [Abstract][Full Text] [Related]
16. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes.
Xiang Y; Liang L; Wang X; Wang J; Zhang X; Zhang Q
J Control Release; 2011 Jun; 152(3):402-10. PubMed ID: 21435361
[TBL] [Abstract][Full Text] [Related]
17. Ultrasound-sensitive siRNA-loaded nanobubbles formed by hetero-assembly of polymeric micelles and liposomes and their therapeutic effect in gliomas.
Yin T; Wang P; Li J; Zheng R; Zheng B; Cheng D; Li R; Lai J; Shuai X
Biomaterials; 2013 Jun; 34(18):4532-43. PubMed ID: 23522375
[TBL] [Abstract][Full Text] [Related]
18. Heavy chain ferritin siRNA delivered by cationic liposomes increases sensitivity of cancer cells to chemotherapeutic agents.
Liu X; Madhankumar AB; Slagle-Webb B; Sheehan JM; Surguladze N; Connor JR
Cancer Res; 2011 Mar; 71(6):2240-9. PubMed ID: 21385903
[TBL] [Abstract][Full Text] [Related]
19. Brain tumor-targeted therapy by systemic delivery of siRNA with Transferrin receptor-mediated core-shell nanoparticles.
Wei L; Guo XY; Yang T; Yu MZ; Chen DW; Wang JC
Int J Pharm; 2016 Aug; 510(1):394-405. PubMed ID: 27374198
[TBL] [Abstract][Full Text] [Related]
20. Tumor-targeting dual peptides-modified cationic liposomes for delivery of siRNA and docetaxel to gliomas.
Yang ZZ; Li JQ; Wang ZZ; Dong DW; Qi XR
Biomaterials; 2014 Jun; 35(19):5226-39. PubMed ID: 24695093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
